Clinical Trial Update: Rofecoxib After Surgery in Treating Patients With Stage II or Stage III Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating rofecoxib after surgery in patients with stage II or stage III colorectal cancer has completed. The trial was sponsored by the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Rofecoxib (rofecoxib)

Snippet

Sponsor: Cancer Research Campaign Clinical Trials Centre | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED